OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS
|
|
- Albert Gaines
- 6 years ago
- Views:
Transcription
1 Journal of the American College of Cardiology Vol. 34, No. 5, by the American College of Cardiology ISSN /99/$20.00 Published by Elsevier Science Inc. PII S (99) Comparison of a Novel Rectilinear Biphasic Waveform With a Damped Sine Wave Monophasic Waveform for Transthoracic Ventricular Defibrillation Suneet Mittal, MD, Shervin Ayati, MSEE,* Kenneth M. Stein, MD, FACC, Bradley P. Knight, MD, Fred Morady, MD, FACC, David Schwartzman, MD, FACC, Doris Cavlovich, RN, BSN, Edward V. Platia, MD, FACC, Hugh Calkins, MD, FACC, Patrick J. Tchou, MD, FACC, John M. Miller, MD, FACC,# J. Marcus Wharton, MD,** Ruey J. Sung, MD, FACC, David J. Slotwiner, MD, Steven M. Markowitz, MD, FACC, Bruce B. Lerman, MD, FACC, for the ZOLL Investigators New York, New York; Burlington, Massachusetts; Ann Arbor, Michigan; Pittsburgh and Philadelphia, Pennsylvania; Washington, DC; Baltimore, Maryland; Cleveland, Ohio; Durham, North Carolina; and Palo Alto, California OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS We compared the efficacy of a novel rectilinear biphasic waveform, consisting of a constant current first phase, with a damped sine wave monophasic waveform during transthoracic defibrillation. Multiple studies have shown that for endocardial defibrillation, biphasic waveforms have a greater efficacy than monophasic waveforms. More recently, a 130-J truncated exponential biphasic waveform was shown to have equivalent efficacy to a 200-J damped sine wave monophasic waveform for transthoracic ventricular defibrillation. However, the optimal type of biphasic waveform is unknown. In this prospective, randomized, multicenter trial, 184 patients who underwent ventricular defibrillation were randomized to receive a 200-J damped sine wave monophasic or 120-J rectilinear biphasic shock. First-shock efficacy of the biphasic waveform was significantly greater than that of the monophasic waveform (99% vs. 93%, p 0.05) and was achieved with nearly 60% less delivered current (14 1 vs. 33 7A,p ). Although the efficacy of the biphasic and monophasic waveforms was comparable in patients with an impedance 70 (100% [biphasic] vs. 95% [monophasic], p NS), the biphasic waveform was significantly more effective in patients with an impedance 70 (99% [biphasic] vs. 86% [monophasic], p 0.02). This study demonstrates a superior efficacy of rectilinear biphasic shocks as compared with monophasic shocks for transthoracic ventricular defibrillation, particularly in patients with a high transthoracic impedance. More important, biphasic shocks defibrillated with nearly 60% less current. The combination of increased efficacy and decreased current requirements suggests that biphasic shocks as compared with monophasic shocks are advantageous for transthoracic ventricular defibrillation. (J Am Coll Cardiol 1999;34: ) 1999 by the American College of Cardiology Multiple studies have shown that for endocardial defibrillation, biphasic waveforms have a greater efficacy than monophasic waveforms (1 6). More recently, a 130-J truncated exponential biphasic waveform was shown to be as effective as a 200-J damped sine wave monophasic waveform for transthoracic ventricular defibrillation (7,8). In addition From the New York Hospital Cornell Medical Center, New York, New York; *Zoll Medical Corporation, Burlington, Massachusetts; University of Michigan Medical Center, Ann Arbor, Michigan; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Washington Hospital Center, Washington, DC; Johns Hopkins University Medical Center, Baltimore, Maryland; Cleveland Clinic Foundation, Cleveland, Ohio; #Temple University Medical Center, Philadelphia, Pennsylvania; **Duke University Medical Center, Durham, North Carolina; and Stanford University Hospital, Palo Alto, California. A complete list of participants and institutions is given in the Appendix. This work was supported in part by grants from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland (RO1 HL56139), the Rosenfeld Foundation, the Michael Wolk Foundation, New York, New York, and the Zoll Medical Corporation, Burlington, Massachusetts. Manuscript received February 11, 1999; revised manuscript received June 18, 1999, accepted June 30, 1999.
2 1596 Mittal et al. JACC Vol. 34, No. 5, 1999 Monophasic vs. Biphasic Shocks for Transthoracic Defibrillation November 1, 1999: Abbreviations and Acronyms ICD implantable cardioverter-defibrillator LV left ventricle or ventricular to increased efficacy, biphasic waveforms, which require less voltage and current for ventricular defibrillation than damped sine wave monophasic waveforms, may result in less post-shock myocardial dysfunction (8 12). Despite the overall advantages of biphasic waveforms, the optimal type of biphasic waveform is unknown. Variables that may affect the efficacy of the biphasic waveform include phase duration (13,14), first-phase tilt (15) and secondphase peak voltage (16,17). A potential limitation of currently available truncated exponential biphasic waveforms is the large drop in current during energy delivery, which limits the average effective current delivered (18). As a result, to maintain an effective average current, a high initial peak current must be delivered, which may be detrimental for myocardial function. In this study, we evaluated a novel rectilinear biphasic waveform that had a constant-current first phase. The potential advantage of a constant-current first phase is that it maintains an effective average current over the entire initial phase of energy delivery without exposing the myocardium to a high initial peak current. We compared the efficacy of this waveform with that of a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. METHODS Study group. This study was a prospective, randomized, multicenter trial comparing the efficacy of a 120-J rectilinear biphasic and a 200-J damped sine wave monophasic waveform during transthoracic ventricular defibrillation. During the study period between November 1997 and August 1998, 330 patients were enrolled from nine centers. Patients were eligible for study if they were undergoing an electrophysiologic study, transvenous implantable cardioverterdefibrillator (ICD) placement, ICD generator replacement or ICD testing. Patients were ineligible if they were 18 years of age, pregnant or currently enrolled in a research study for a medication or device. The Institutional Review Board at each participating institution approved the investigational protocol. Informed written consent was obtained from all patients. Study design. The primary hypothesis of the study was that a 120-J biphasic shock would have the same first-shock defibrillation efficacy as a 200-J monophasic shock. Assuming a first-shock success rate of 85% with the 200-J damped sine wave monophasic waveform and 70% with the 120-J rectilinear biphasic waveform, a study sample of 154 patients was required to detect a 15% difference in Figure 1. Defibrillation waveforms. Top, Representative 200-J damped sine wave shock delivered across a 50- load. Bottom, Representative 120-J rectilinear biphasic waveform delivered across a 50- load. efficacy between the monophasic and biphasic waveforms with a power of 80% and a significance level of Shock waveforms. Figure 1 depicts a representative 200-J damped sine wave monophasic waveform and a 120-J rectilinear (constant-current first phase) biphasic waveform delivered across a 50- load. The monophasic waveforms were generated from a ZOLL PD-2000 defibrillator (Burlington, Massachusetts) by delivering the stored charge on a 45- F capacitor through a 20-mH inductor and an internal resistance of 14. Biphasic waveforms were generated from a 100- F capacitor using the ZOLL PD-2100 defibrillator. The biphasic waveform consisted of a constant-current 6-ms first-phase pulse followed by a truncated exponential 4-ms second-phase pulse. The time between the trailing edge of the first phase and the leading edge of the second phase was 100 s. For biphasic shocks, a constant-current first phase was maintained by automatically adjusting the variable internal impedance based on the patient s transthoracic impedance, which was determined at the onset of shock delivery. Switching resistors provided a constant first-phase current as well as the step ripple. The amplitude of the first and second phases varied with the selected energy. The initial amplitude of the second phase was approximately equal to the final amplitude of the first phase.
3 JACC Vol. 34, No. 5, 1999 November 1, 1999: Mittal et al. Monophasic vs. Biphasic Shocks for Transthoracic Defibrillation 1597 Table 1. Effect of Transthoracic Impedance on Delivered Current (A) J biphasic shock J biphasic shock J biphasic shock J monophasic shock J monophasic shock J monophasic shock The effect of transthoracic impedance on delivered current for the monophasic and biphasic waveforms is outlined in Table 1. An initial 120-J biphasic shock was chosen for several reasons. First, for the waveforms used in this study, the mean ratio of biphasic threshold current to peak damped sine wave monophasic current was (unpublished data). Because the mean current required for defibrillation with a monophasic damped sine wave is 25 to 30 A (19,20), we surmised that the biphasic waveform should deliver 9 to 11 A. The 120-J rectilinear biphasic waveform delivers between 12 and 16 A for transthoracic impedances between 50 and 125 (Table 1). To confirm our assumptions, we conducted a pilot human study involving 20 patients (15 men, age years) during 22 episodes of an induced ventricular tachyarrhythmia requiring defibrillation. The first 10 patients (10 total episodes) were treated with a 150-J biphasic shock, which was effective in all of them. The next 10 patients (12 total episodes) were treated with a 120-J biphasic shock. The first-shock efficacy was 92% (11 of 12 episodes). We therefore elected to use a 120-J biphasic shock in the present study. Shock electrodes. Adhesive pads (ZOLL Radiolucent Stat-Padz) for transthoracic defibrillation were applied to the cardiac apex, to the left fifth intercostal space in the anterior axillary line and to the left scapula posteriorly. The apical electrode had an active surface area of 78 cm 2 and the posterior electrode had an active surface area of 113 cm 2. The defibrillation pads were connected to a multipledefibrillation interface unit, which in turn was connected to the monophasic and biphasic defibrillators. The interface unit measured the voltage and current delivered to the patient as well as the patient s impedance. This information was transmitted to a laptop personal computer that was also connected to the interface unit. Defibrillation testing. During electrophysiologic study or ICD testing, ventricular fibrillation, ventricular flutter or polymorphic or rapid monomorphic (cycle length 300 ms) ventricular tachycardia was induced with either alternating current, programmed stimulation, a T-wave shock or burst ventricular pacing. Patients were randomized, using a simple block randomization scheme, to either the monophasic (Fig. 2) or Figure 2. Monophasic waveform protocol. The initial shock was a 200-J damped sine wave monophasic shock. If the initial shock failed to defibrillate, the patient received a 300-J shock, and if that was unsuccessful, a 360-J shock was delivered. If all three monophasic shocks were unsuccessful, a 170-J biphasic shock was delivered. biphasic waveform (Fig. 3) protocol. In brief, patients randomized to the monophasic protocol received sequential shocks of 200 J, 300 J and 360 J, if necessary. Patients randomized to the biphasic protocol received sequential shocks of 120 J, 150 J and 170 J, if necessary. Figure 3. Biphasic waveform protocol. The initial shock was a 120-J biphasic shock. If the initial shock failed to defibrillate, the patient received a 150-J shock, and if that was unsuccessful, a 170-J shock was delivered. If all three biphasic shocks were unsuccessful, a 360-J damped sine wave monophasic shock was delivered. In addition, this protocol was applied to all patients, regardless of initial randomization, when an additional induction of ventricular fibrillation was required.
4 1598 Mittal et al. JACC Vol. 34, No. 5, 1999 Monophasic vs. Biphasic Shocks for Transthoracic Defibrillation November 1, 1999: Table 2. Patient Characteristics and Clinical Demographic Data No. of Patients (%) Biphasic Group n 98 (53%) Monophasic Group n 86 (47%) Total n 184 Age (yr) Gender Male 80 (82%) 63 (73%) 143 (78%) Female 18 (18%) 23 (27%) 41 (22%) Weight (kg) Body surface area (m 2 ) LVEF (%) Cardiac disease Coronary artery disease 67 (68%) 60 (70%) 127 (69%) Idiopathic cardiomyopathy 20 (20%) 14 (16%) 34 (18%) None 4 (4%) 3 (4%) 7 (4%) Other 7 (8%) 9 (10%) 16 (9%) Medications ACE inhibitor 51 (52%) 47 (55%) 98 (53%) Amiodarone 21 (21%) 21 (24%) 42 (23%) Beta-blocker 38 (39%) 36 (42%) 74 (40%) Calcium channel blocker 9 (9%) 8 (9%) 17 (9%) Nitrate 19 (19%) 21 (24%) 40 (22%) Diuretic 40 (41%) 40 (47%) 80 (44%) Procedure Electrophysiologic study 39 (40%) 32 (37%) 71 (38%) ICD placement 8 (8%) 10 (12%) 18 (10%) ICD generator change 3 (3%) 2 (2%) 5 (3%) ICD test 48 (49%) 42 (49%) 90 (49%) Induced arrhythmia episodes Ventricular fibrillation 74 (76%) 72 (84%) 146 (79%) Monomorphic ventricular tachycardia 15 (15%) 8 (9%) 23 (13%) Ventricular flutter 6 (6%) 4 (5%) 10 (5%) Polymorphic ventricular tachycardia 3 (3%) 2 (2%) 5 (3%) p NS for all comparisons between monophasic and biphasic groups. Data are presented as mean value SD or number (%) of patients. ACE angiotensin-converting enzyme inhibitor; ICD implantable cardioverter-defibrillator; LVEF left ventricular ejection fraction. To obtain maximal experience with the biphasic waveform, all patients, regardless of randomization, were treated according to the biphasic waveform protocol during subsequent inductions of a ventricular tachyarrhythmia. No patient underwent defibrillation with a previously unsuccessful waveform. Successful defibrillation was defined as conversion of ventricular tachycardia or ventricular fibrillation to a supraventricular or paced rhythm associated with a measurable blood pressure and pulse that persisted for at least 30 s post shock. A minimum of 3 min was allowed between serial inductions of ventricular fibrillation. Statistical analysis. All continuous variables are expressed as the mean value SD. Comparisons of dichotomous and continuous variables between the monophasic and biphasic waveform groups were calculated using the chisquare test and the Student t test, respectively. The firstshock efficacy of the 120-J biphasic and 200-J monophasic shocks were compared using the Fisher exact test. For all comparisons, p 0.05 was considered to be statistically significant. RESULTS Patient characteristics. Of the 330 patients enrolled in the study, 194 required transthoracic defibrillation. The 136 patients who did not undergo defibrillation were excluded from further analysis. An additional 10 patients were excluded owing to cardioversion of monomorphic ventricular tachycardia with a cycle length 300 ms (n 5) (21), insufficient data collection (n 2), incorrect randomization (n 2) and inadvertent duplicate enrollment (n 1). The remaining 184 patients constituted the study group. The patients mean age was years and the left ventricular (LV) ejection fraction was 30 15%. Coronary artery disease was present in 69% of patients. Of the 184 patients who underwent defibrillation, 98 (53%) were randomized to the biphasic group and 86 (47%) to the monophasic group. The two groups were similar with respect to age, gender, weight, body surface area, LV ejection fraction, underlying cardiac disease, type of study performed, use of medications (including amiodarone) and type of induced ventricular arrhythmia (Table 2).
5 JACC Vol. 34, No. 5, 1999 November 1, 1999: Mittal et al. Monophasic vs. Biphasic Shocks for Transthoracic Defibrillation 1599 Table 3. First-Shock Defibrillation Data for Monophasic and Biphasic Waveform Groups No. of Patients Delivered Energy (J) Voltage (V) Current (A) Impedance Arrhythmia Duration (s) First-Shock Success Rate Monophasic % (80/86) (200 J)* ( ) (1,051 2,593) (17 56) (25 114) (3 51) Biphasic % (97/98) (120 J)* (77 151) (445 1,260) (11 18) (30 112) (3 134) p Value NS 0.05 *Energy delivered into a 50- load. Data are presented as mean value SD (range). Defibrillation data. The 184 patients underwent defibrillation of 219 episodes of a ventricular tachyarrhythmia. For the first induction of a ventricular tachyarrhythmia, firstshock efficacy was observed in 97 (99%) of 98 patients receiving a 120-J biphasic shock. In contrast, first-shock efficacy was observed in only 80 (93%, p 0.05) of 86 patients receiving a 200-J damped sine wave monophasic shock. In addition, successful defibrillation with biphasic shocks was achieved with 58% less voltage ( vs V, p ) and 58% less current (14 1 vs A, p ) than that delivered with monophasic shocks (Table 3). Defibrillation for a second induction of a ventricular tachyarrhythmia was required in 29 patients and for a third induction in six patients. No patient was induced more than three times. Twenty-six of the 29 patients who underwent defibrillation for a second induction were treated with the 120-J biphasic waveform, which was effective in all 26 patients. Three of the 29 patients during a second induction were inadvertently defibrillated with a 200-J monophasic shock rather than a 120-J biphasic shock. The shock was effective in two of the three patients. However, because repeat monophasic shocks constituted a protocol violation, these three patients were excluded from further analysis. All six patients who underwent a third induction were treated with the 120-J biphasic waveform, which was effective in all six patients. Therefore, the first-shock success for all inductions treated with the biphasic waveform (129 [99%] of 130 episodes) was significantly greater than that treated with the monophasic waveform (80 [93%] of 86 episodes, p 0.02). The only patient who initially failed a 120-J biphasic shock was successfully defibrillated with a second 150-J biphasic shock. No patient in this study required a 170-J biphasic shock. Six patients failed an initial 200-J monophasic shock. Of these 6 patients, 3 were converted with a second 300-J monophasic shock, 1 required a 360-J monophasic shock (after an additional failure with 300 J) and 2 received a rescue ICD shock before delivery of a 300-J monophasic shock. There were no complications related to either monophasic or biphasic shocks. The patients age, gender, weight, body surface area, LV ejection fraction and underlying cardiac disease did not affect defibrillation efficacy. However, defibrillation efficacy was significantly influenced by the patient s impedance. In patients with a transthoracic impedance 70, the firstshock efficacy of the monophasic waveform (40 [95%] of 42 episodes) was comparable to that of the biphasic waveform (58 [100%] of 58 episodes, p NS). However, in patients with a transthoracic impedance 70, the first-shock efficacy of the biphasic waveform was greater than that of the monophasic waveform (67 [99%] of 68 vs. 24 [86%] of 28 episodes, p 0.02). A similar advantage for the biphasic waveform was observed in patients with an impedance 90 (19 [100%] of 19 vs. 5 [63%] of 8 episodes for the monophasic waveform, p 0.02). DISCUSSION The principal finding of this study is that transthoracic ventricular defibrillation with 120-J rectilinear biphasic shocks is more efficacious than that with 200-J damped sine wave monophasic shocks, particularly in patients with a high transthoracic impedance. In addition, successful defibrillation with biphasic shocks could be achieved with nearly 60% less current than that delivered with monophasic shocks. Although most currently available defibrillators use an energy-calibrated method for defibrillation, transthoracic current appears to be a more precise electrical descriptor of defibrillation threshold (19,22). Defibrillation using an energy-calibrated method may be suboptimal because, for a given energy, current is dependent on transthoracic impedance (Table 1). Therefore, insufficient current may be delivered to patients with high impedance (decreased efficacy), and excessive current may be delivered to patients with low transthoracic impedance (increased toxicity). Manifestations of toxicity include myocardial dysfunction (23,24), reflected by ST segment changes as well as a decline in the cardiac index, and provocation of arrhythmias (10,25), including ventricular tachyarrhythmias and atrioventricular block. Efforts to circumvent this limitation have resulted in defibrillator designs that vary the waveform duration, automatically increase energy output in patients (26) with high impedance or deliver a fixed current dose independent of the patient s impedance (18,26). The results of this study also suggest that a rectilinear biphasic waveform offers an advantage with respect to patients with high impedance, because it is not affected by changes in the transthoracic impedance to the same degree as the damped sine wave monophasic waveform (Table 1).
6 1600 Mittal et al. JACC Vol. 34, No. 5, 1999 Monophasic vs. Biphasic Shocks for Transthoracic Defibrillation November 1, 1999: For example, the peak current delivered to a patient with 125- impedance from a 200-J damped sine wave monophasic shock is only 56% of that delivered to patient with 50- impedance. In contrast, the first-phase current delivered by a 120-J rectilinear biphasic shock to a patient with 125- impedance is 75% of that delivered to a patient with 50- impedance, thus reducing the adverse effect of an increased transthoracic impedance on delivered current (27). Consistent with this potential advantage was the greater first-shock success of the biphasic waveform in patients with 70 impedance. It is important to note that on the basis of the spectrum of transthoracic impedance observed in this study, this advantage is applicable to 50% of patients undergoing defibrillation. Several studies of endocardial defibrillation as well as one recent study of transthoracic defibrillation have demonstrated lower defibrillation threshold voltage and current with biphasic waveforms as compared with monophasic waveforms (1 8). Regardless of the mechanism for this benefit, which may be related to recovery of sodium channel activity during the first phase of the biphasic shock (28), it is generally accepted that defibrillation with lower voltage and current is desirable owing to a decreased likelihood of post-shock myocardial dysfunction (8 12). Previous studies. There is one other randomized study that compared the efficacy of monophasic versus biphasic waveforms during transthoracic ventricular defibrillation (8). This study compared truncated exponential biphasic waveforms (115 J and 130 J) generated with a 95- F capacitor with damped sine wave monophasic waveforms (200 J and 360 J) generated with a 32- F capacitor through a 50-mH inductor with 10- internal resistance. The individual phase duration, total duration and tilt of the biphasic waveform varied according to the transthoracic impedance of the patient. An equivalent first-shock efficacy was demonstrated for the 130-J biphasic (86% success) and the 200-J (86% success) waveforms. The greatest efficacy was demonstrated for the 360-J damped sine wave monophasic shock, which had a first-shock efficacy of 96%. This has raised concern that low energy biphasic shocks may be less efficacious than 360-J damped sine wave monophasic shocks (29). However, the first-shock efficacy for the 120-J biphasic waveform in our study was 99%, which approximates the efficacy of the 360-J damped sine wave monophasic shock in the previous study. It remains to be determined whether differences in efficacy between our study and the previous study are related to differences in the biphasic waveforms. A direct comparison between the truncated exponential and rectilinear biphasic waveforms was not currently possible because the former was not available for hospital-based defibrillation. Conclusions. This study demonstrates that 120-J rectilinear biphasic shocks have a greater efficacy than 200-J damped sine wave monophasic shocks for transthoracic ventricular defibrillation, particularly in patients with a high transthoracic impedance. In addition, ventricular defibrillation was achieved with less delivered current. The combination of increased efficacy and decreased current requirements suggests that biphasic shocks as compared with monophasic shocks are advantageous for transthoracic ventricular defibrillation. APPENDIX: INVESTIGATORS AND PARTICIPATING INSTITUTIONS Principal investigators: Hugh Calkins, MD, and Rozann Hansford, RN (Johns Hopkins University Medical Center, Baltimore, Maryland); Bradley P. Knight, MD, Fred Morady, MD, and Karin M. Brinkman, MS, (University of Michigan Medical Center, Ann Arbor, Michigan); Bruce B. Lerman, MD, Kenneth M. Stein, MD, Steven M. Markowitz, MD, Suneet Mittal, MD, David J. Slotwiner, MD, Maliza Sarmiento, RN, MA, ANP, and Mary Wong, RN, MSN, ANP (New York Hospital Cornell Medical Center, New York, New York); John M. Miller, MD, and Lisa Thome (Temple University Medical Center, Philadelphia, Pennsylvania); Edward V. Platia, MD, Jean Fenton, RN, MSN, and Dulce Manno, RN, MHSA (Washington Hospital Center, Washington, DC); David Schwartzman, MD, and Doris Cavlovich, RN, BSN (University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania); Ruey J. Sung, MD, and Michelle Lamoureux, RN, MS (Stanford University Hospital, Palo Alto, California); Patrick J. Tchou, MD, and Donald R. Holmes, RN, MSN (Cleveland Clinic Foundation, Cleveland, Ohio); and J. Marcus Wharton, MD, and Catherine Grill, RN, BSN (Duke University Medical Center, Durham, North Carolina). Reprint requests and correspondence: Dr. Bruce B. Lerman, Division of Cardiology, The New York Hospital Cornell Medical Center, 525 East 68th Street, Starr 4, New York, New York blerman@mail.med.cornell.edu. REFERENCES 1. Fain ES, Sweeney MB, Franz MR. Improved internal defibrillation efficacy with a biphasic waveform. Am Heart J 1989;117: Winkle RA, Mead RH, Ruder MA, et al. Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform. Am Heart J 1989;117: Chapman PD, Vetter JW, Souza JJ, Troup PJ, Wetherbee JN, Hoffmann RG. Comparative efficacy of monophasic and biphasic truncated exponential shocks for nonthoracotomy internal defibrillation in dogs. J Am Coll Cardiol 1988;12: Bardy GH, Ivey TD, Allen MD, Johnson G, Mehra R, Greene HL. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol 1989;14: Kavanagh KM, Tang ASL, Rollins DL, Smith WM, Ideker RE. Comparison of the internal defibrillation thresholds for monophasic and double and single capacitor biphasic waveforms. J Am Coll Cardiol 1989;14: Wyse DG, Kavanagh KM, Gillis AM, et al. Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. Am J Cardiol 1993;71: Bardy GH, Gliner BE, Kudenchuk PJ, et al. Truncated biphasic pulses for transthoracic defibrillation. Circulation 1995;91:
7 JACC Vol. 34, No. 5, 1999 November 1, 1999: Mittal et al. Monophasic vs. Biphasic Shocks for Transthoracic Defibrillation Bardy GH, Marchlinski FE, Sharma AD, et al. Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Circulation 1996;94: Warner ED, Dahl C, Ewy GA. Myocardial injury from transthoracic defibrillator countershock. Arch Pathol 1975;99: Weaver WD, Cobb LA, Copass MK, Hallstrom AP. Ventricular defibrillation comparative trial using 175-J and 320-J shocks. N Engl J Med 1982;307: Jones JL, Jones RE. Decreased defibrillator-induced dysfunction with biphasic rectangular waveforms. Am J Physiol 1984;247:H Tung L. Detrimental effects of electrical fields on cardiac muscle. Proc IEEE 1996;84: Tang ASL, Yabe S, Wharton JM, Dolker M, Smith WM, Ideker RE. Ventricular defibrillation using biphasic waveforms: the importance of phasic duration. J Am Coll Cardiol 1989;13: Swerdlow CD, Fan W, Brewer JE. Charge-burping theory correctly predicts optimal ratios of phase duration for biphasic defibrillation waveforms. Circulation 1996;94: Yamanouchi Y, Mowrey KA, Kroll MW, et al. Optimized first phase tilt in parallel-series biphasic waveform. J Cardiovasc Electrophysiol 1997;8: Yamanouchi Y, Mowrey KA, Nadzam GR, et al. Large change in voltage at phase reversal improves biphasic defibrillation thresholds: parallel-series mode switching. Circulation 1996;94: Tomassoni G, Newby K, Deshpande S, et al. Defibrillation efficacy of commercially available biphasic impulses in humans: importance of negative-phase peak voltage. Circulation 1997;95: Yamanouchi Y, Brewer JE, Mowrey KA, et al. Sawtooth first phase biphasic defibrillation waveform: a comparison with standard waveform in clinical devices. J Cardiovasc Electrophysiol 1997;8: Lerman BB, DiMarco JP, Haines DE. Current-based versus energybased ventricular defibrillation: a prospective study. J Am Coll Cardiol 1988;12: Dalzell GWN, Cunningham SR, Anderson J, Adgey AAJ. Initial experience with a microprocessor controlled current based defibrillator. Br Heart J 1989;61: Kerber KE, Kienzle MG, Olshansky B, et al. Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion. Circulation 1992;85: Lerman BB, Halperin HR, Tsitlik JE, Brin K, Clark CW, Deale OC. Relationship between canine transthoracic impedance and defibrillation threshold: evidence for current-based defibrillation. J Clin Invest 1987;80: Eysmann SB, Marchlinski FE, Buxton AE, Josephson ME. Electrocardiographic changes after cardioversion of ventricular arrhythmias. Circulation 1986;73: Tokano T, Bach D, Chang J, et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 1998;9: Adgey AAJ, Patton JN, Campbell NPS, Webb SW. Ventricular defibrillation: appropriate energy levels. Circulation 1979;60: Kerber RE, McPherson D, Charbonnier F, Kieso R, Hite P. Automated impedance-based energy adjustment for defibrillation: experimental studies. Circulation 1985;71: Kerber RE, Kouba C, Martins J, et al. Advance prediction of transthoracic impedance in human defibrillation and cardioversion: importance of impedance in determining the success of low-energy shocks. Circulation 1984;70: Jones JL, Tovar OH. The mechanism of defibrillation and cardioversion. Proc IEEE 1996;84: Cummins RO, Hazinski MF, Kerber RE, et al. Low-energy biphasic waveform defibrillation: evidence-based review applied to emergency cardiovascular care guidelines. Circulation 1998;97:
Atrial fibrillation is the most commonly encountered
Transthoracic Cardioversion of Atrial Fibrillation Comparison of Rectilinear Biphasic Versus Damped Sine Wave Monophasic Shocks Suneet Mittal, MD; Shervin Ayati, MSEE; Kenneth M. Stein, MD; David Schwartzman,
More informationComparative Efficacy of Triphasic and Biphasic Internal Defibrillation
224 Vol. 8, No. 4, December 2003 Comparative Efficacy of Triphasic and Biphasic Internal Defibrillation K. MISCHKE, M. ZARSE, K. BREHMER, C. STELLBRINK, P. HANRATH, P. SCHAUERTE Department of Cardiology,
More informationTriphasic Waveforms Are Superior to Biphasic Waveforms for Transthoracic Defibrillation Experimental Studies
Journal of the American College of Cardiology Vol. 42, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00656-9
More informationM Series with Rectilinear Biphasic Waveform Defibrillator Option Indications for Use
DEFIBRILLATOR OPTION General Information Introduction M Series products are available with an advanced electrical design that provides a unique rectilinear biphasic waveform for defibrillation and cardioversion.
More informationBiphasic Clinical Summaries
Biphasic Clinical Summaries Defibrillation of Ventricular Fibrillation and Ventricular Tachycardia Background Physio-Control conducted a multi-centered, prospective, randomized and blinded clinical trial
More informationEuropace (2001) 3, doi: /eupc , available online at on
Europace (21) 3, 278 284 doi:1.153/eupc.21.184, available online at http://www.idealibrary.com on ICDs Clinical evaluation of defibrillation efficacy with a new single-capacitor biphasic in patients undergoing
More informationDEFIBRILLATORS. Prof. Yasser Mostafa Kadah
DEFIBRILLATORS Prof. Yasser Mostafa Kadah Basics Defibrillation is definitive treatment for life-threatening cardiac arrhythmias such as ventricular fibrillation Defibrillation consists of delivering therapeutic
More informationRise in Chronic Defibrillation Energy Requirements Necessitating Implantable Defibrillator Lead System Revision
Rise in Chronic Defibrillation Energy Requirements Necessitating Implantable Defibrillator Lead System Revision EMILE G. DAOUD, K. CHING MAN, ERED MORADY, and S. ADAM STRIGKBERGER From the Division of
More informationThe Facts about Biphasic Defibrillation
The Facts about Biphasic Defibrillation Introduction In reference to the SMART Biphasic waveform, Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, published by the American
More informationSMART Biphasic. A Proven, Fixed, Low-Energy Defibrillation Waveform
SMART Biphasic A Proven, Fixed, Low-Energy Defibrillation Waveform INTRODUCTION The 1990s heralded a new era of transthoracic defibrillation in which the rules of conventional practice no longer apply.
More informationManual Defibrillators, Automatic External Defibrillators, Cardioversion, and External Pacing. D. J. McMahon cewood rev
Manual Defibrillators, Automatic External Defibrillators, Cardioversion, and External Pacing D. J. McMahon 141001 cewood rev 2017-10-04 Key Points Defibrillators: - know the definition & electrical value
More informationDEFIBRILLATORS ATRIAL AND VENTRICULAR FIBRILLATION
1 DEFIBRILLATORS The two atria contract together and pump blood through the valves into the two ventricles, when the action potentials spread rapidly across the atria surface. After a critical time delay,
More informationReview Article The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
www.ipej.org 289 Review Article The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation Simon J Walsh, MD MRCP; Ben M Glover, MB BCh MRCP; AA Jennifer Adgey, MD FRCP FACC Regional
More informationOBJECTIVE. 1. Define defibrillation. 2. Describe Need and history of defibrillation. 3. Describe the principle and mechanism of defibrillation.
Defibrillators OBJECTIVE 1. Define defibrillation. 2. Describe Need and history of defibrillation. 3. Describe the principle and mechanism of defibrillation. 4. Types and classes of defibrillator 5. Describe
More informationImplantable Cardioverter-Defibril. Defibrillators. Ratko Magjarević
Implantable Cardioverter-Defibril Defibrillators Ratko Magjarević University of Zagreb Faculty of Electrical Engineering and Computing Croatia ratko.magjarevic@fer.hr Ventricular Fibrillation Ventricular
More informationAn Experimental Study of Transvenous Defibrillation Using a Coronary Sinus Catheter
An Experimental Study of Transvenous Defibrillation Using a Coronary Sinus Catheter ALAN H. KADISH, M.D., KEITH CHILDS, B.S., and JOSEPH LEVINE, M.D. From the Division of Cardiology, Department of Internal
More informationImplantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk
More informationAtrial Defibrillation With a Transvenous Lead A Randomized Comparison of Active Can Shocking Pathways
Journal of the American College of Cardiology Vol. 34, No. 2, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00214-4 Atrial
More informationJournal of the American College of Cardiology Vol. 36, No. 3, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 36, No. 3, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00781-6 Monophasic
More informationJournal of the American College of Cardiology Vol. 35, No. 2, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 2, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00579-3 High
More informationManual Defibrillators, Automatic External Defibrillators, Cardioversion, and External Pacing
Manual Defibrillators, Automatic External Defibrillators, Cardioversion, and External Pacing Key Points Defibrillators: - know the definition & electrical value of a joule - monophasic vs biphasic types:
More informationArrhythmia/Electrophysiology
Arrhythmia/Electrophysiology Ascending-Ramp Biphasic Waveform Has a Lower Defibrillation Threshold and Releases Less Troponin I Than a Truncated Exponential Biphasic Waveform Jian Huang, MD, PhD; Gregory
More informationA Prospective Study Comparing the Sensed R Wave in Bipolar and Extended Bipolar Configurations: The PropR Study
A Prospective Study Comparing the Sensed R Wave in Bipolar and Extended Bipolar Configurations: The PropR Study ANEESH V. TOLAT, M.D.,* MELISSA WOICIECHOWSKI, M.S.N.,* ROSEMARIE KAHR, R.C.I.S.,* JOSEPH
More informationEHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs
EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important step for
More informationAtrial fibrillation or atrial flutter (AF) may occur after
Relation of Atrial Refractoriness to Upper and Lower Limits of Vulnerability for Atrial Fibrillation/Flutter Following Implantable Ventricular Defibrillator Shocks Amos Katz, MD; Robert J. Sweeney, PhD;
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationICD: Basics, Programming and Trouble-shooting
ICD: Basics, Programming and Trouble-shooting Amir AbdelWahab, MD Electrophysiology and Pacing Service Cardiology Department Cairo University Feb 2013 Evolution of ICD Technology ICD Evolution Indications
More informationDefibrillation threshold testing should no longer be performed: contra
Defibrillation threshold testing should no longer be performed: contra Andreas Goette St. Vincenz-Hospital Paderborn Dept. of Cardiology and Intensive Care Medicine Germany No conflict of interest to disclose
More informationJournal of the American College of Cardiology Vol. 33, No. 7, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 7, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00148-5 Outcome
More informationSubcutaneous implantable cardioverter-defibrillator (S-ICD)
NEW DRUGS AND TECHNOLOGIES IN CARDIOLOGY Cardiology Journal 2011, Vol. 18, No. 3, pp. 326 331 Copyright 2011 Via Medica ISSN 1897 5593 Subcutaneous implantable cardioverter-defibrillator (S-ICD) S. Suave
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More informationPERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists
PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists Craig A. McPherson, MD, FACC Associate Professor of Medicine Constantine Manthous, MD, FACP, FCCP Associate Clinical
More informationEffects of Polarity for Monophasic and Biphasic Shocks on Defihrillation Efficacy with an Endocardiai System
Effects of Polarity for Monophasic and Biphasic Shocks on Defihrillation Efficacy with an Endocardiai System MASAHIRO USUI, GREGORY P. WALCOTT, S. ADAM STRICKBERGER,* DENNIS L. ROLLINS, WILLIAM M. SMITH,
More informationPacemaker System Malfunction Resulting from External Electrical Cardioversion: A Case Report
Case Report Pacemaker System Malfunction Resulting from External Electrical Cardioversion: A Case Report Taku Nishida MD, Tamio Nakajima MD, PhD, Yutaka Goryo MD, Ken-ichi Ishigami MD, PhD, Hiroyuki Kawata
More informationSupplemental Material
Supplemental Material 1 Table S1. Codes for Patient Selection Cohort Codes Primary PM CPT: 33206 or 33207 or 33208 (without 33225) ICD-9 proc: 37.81, 37.82, 37.83 Primary ICD Replacement PM Replacement
More informationTransvenous Biventricular Defibrillation Halves Energy Requirements in Patients
Transvenous Biventricular Defibrillation Halves Energy Requirements in Patients Christian Butter, MD; Eckhard Meisel, MD; Juergen Tebbenjohanns, MD; Lothar Engelmann, MD; Eckart Fleck, MD; Bernd Schubert,
More informationThe Multicenter Unsustained Tachycardia Trial (MUSTT)
Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial Kerry L. Lee, PhD; Gail Hafley, MS; John D. Fisher, MD; Michael R. Gold, MD; Eric
More informationImplantable cardioverter defibrillator, Inappropriate shock, Lead failure
Inappropriate Discharges of Intravenous Implantable Cardioverter Defibrillators Owing to Lead Failure Takashi WASHIZUKA, 1 MD, Masaomi CHINUSHI, 1 MD, Ryu KAZAMA, 1 MD, Takashi HIRONO, 1 MD, Hiroshi WATANABE,
More informationEfficacy and safety of the reciprocal pulse defibrillator current waveform
Purdue University Purdue e-pubs Weldon School of Biomedical Engineering Faculty Publications Weldon School of Biomedical Engineering 1984 Efficacy and safety of the reciprocal pulse defibrillator current
More informationPublished in: European Heart Journal
Impedance compensated biphasic waveforms for transthoracic cardioversion of artrial fibrillation: a multi-centre comparison of anteroapical and antero-posterior pad positions Walsh, S. J., McCarty, D.,
More informationReduction in Defibrillator Shocks With an Implantable Device Combining Antitachycardia Pacing and Shock Therapy
JACC Vol. 18, No. I 145 CARDIAC PACING Reduction in Defibrillator Shocks With an Implantable Device Combining Antitachycardia Pacing and Shock Therapy JAMES w. LEITCH, MBBS, ANNE M. GILLIS, MD, D. GEORGE
More informationNovel Passive Implantable Atrial Defibrillator Using Transcutaneous Radiofrequency Energy Transmission Successfully Cardioverts Atrial Fibrillation
Novel Passive Implantable Atrial Defibrillator Using Transcutaneous Radiofrequency Energy Transmission Successfully Cardioverts Atrial Fibrillation Ganesh Manoharan, MD; Noel Evans, PhD; Bakthiar Kidwai,
More informationEffect of a Passive Endocardial Electrode on Defibrillation Efficacy of a Nonthoracotomy Lead System
JACC Vol. 29, No. 4 March 15, 1997:825 30 825 Effect of a Passive Endocardial Electrode on Defibrillation Efficacy of a Nonthoracotomy Lead System PARWIS C. FOTUHI, MD, BRUCE H. KENKNIGHT, MS,* SHARON
More informationExternal Cardioversion in Patients With Persistent Atrial Fibrillation
External Cardioversion in Patients With Persistent Atrial Fibrillation A Reappraisal of the Effects of Electrode Pad Position and Transthoracic Impedance on Cardioversion Success Chien-Jen CHEN, 1 MD,
More informationEffect of Shock Thning on Efficacy and Safety Cardioverso on for Ventricular Tachycardia
JAM Vol. 24. No. 3 September 1994 : 70 3 -ti 703 ELECTROPHYSIOLOGY Effect of Shock Thning on Efficacy and Safety Cardioverso on for Ventricular Tachycardia of Internal HUAGUI G. LI, MD, PHD, RAYMOND YEE,
More informationEBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA
Over 200,000 patients worldwide are estimated to receive a CRT device each year. However, limitations prevent some patients from benefiting. CHALLENGING PROCEDURE 5% implanted patients fail to have coronary
More informationAutomatic Identification of Implantable Cardioverter-Defibrillator Lead Problems Using Intracardiac Electrograms
Automatic Identification of Implantable Cardioverter-Defibrillator Lead Problems Using Intracardiac Electrograms BD Gunderson, AS Patel, CA Bounds Medtronic, Inc., Minneapolis, USA Abstract Implantable
More informationDiagnostic Value of Single Versus Dual Chamber Electrograms Recorded from an Implantable Defibrillator
Journal of Interventional Cardiac Electrophysiology 9, 49 53, 2003 C 2003 Kluwer Academic Publishers. Manufactured in The Netherlands. Diagnostic Value of Single Versus Dual Chamber Electrograms Recorded
More informationVisualization of Defibrillation Simulation Using Multiple Transthoracic Electrodes
Visualization of Defibrillation Simulation Using Multiple Transthoracic Electrodes Joseph Qualls, 1 David J. Russomanno, 1 Amy de Jongh Curry, 2 and Deepika Konakanchi 2 1 Department of Electrical and
More informationCardiac Electrical Therapies. By Omar AL-Rawajfah, PhD, RN
Cardiac Electrical Therapies By Omar AL-Rawajfah, PhD, RN Outlines What are cardiac electrical therapies Ablation Defibrillation Cardioversion What are the nursing considerations for each type of therapy
More informationEarly Defibrillation. Dr. M. Ravishankar
Early Defibrillation Dr. M. Ravishankar THE CHAIN OF SURVIVAL CONCEPT Early Access Early CPR Early Defibrillation Early Advance Care 1 st Link 2 nd Link 3 rd Link 4 th Link Why early defibrillation VF
More informationDefibrillator Electrode-Chest Wall Coupling Agents: Influence on Transthoracic Impedance and Shock Success
682 JACC Vol. 6. No.3 Defibrillator Electrode-Chest Wall Coupling Agents: Influence on Transthoracic Impedance and Shock Success PHILIP E. AYLWARD, BM, FRACP, ROBERT KIESO, MS, PAMELA HlTE, BS, FRANCIS
More informationThe Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia
The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology
More informationAssessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis
Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis Investigator: Keiko Saito, MD Mentor: Yuji Saito, MD, PhD, FACP, FACC Department
More informationComplications Associated With Pectoral Cardioverter-Defibrillator Implantation: Comparison of Subcutaneous and Submuscular Approaches
1278 JACC Vol. 28, No. 5 Complications Associated With Pectoral Cardioverter-Defibrillator Implantation: Comparison of Subcutaneous and Submuscular Approaches MICHAEL R. GOLD, MD, PHD, FACC, ROBERT W.
More informationResults of Catheter Ablation of Ventricular Tachycardia Using Direct Current Shocks
Results of Catheter Ablation of Ventricular Tachycardia Using Direct Current Shocks FRED MORADY, MELVIN M. SCHEINMAN, JERRY C. GRIFFIN, JOHN M. HERRE, and WILLIAM H. KOU From the Divisions of Cardiology,
More informationHow to Approach the Patient with CRT and Recurrent Heart Failure
How to Approach the Patient with CRT and Recurrent Heart Failure Byron K. Lee MD Associate Professor of Medicine Electrophysiology and Arrhythmia Section UCSF Update in Electrocardiography and Arrhythmias
More informationPrimary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life
Chapter 3 Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Guido H. van Welsenes, MS, Johannes B. van Rees, MD, Joep Thijssen, MD, Serge
More informationThe Nuts and Bolts of ICD Therapy
Electrical Management of Cardiac Rhythm Disorders For Cardiology Fellows December 5-8 Austin, Texas The Nuts and Bolts of ICD Therapy 1 2 Action Potential Localized Differences in Conduction Conduction
More informationAnalysis During Sinus Rhythm of Critical Sites in Reentry Circuits of Postinfarction Ventricular Tachycardia
Journal of Interventional Cardiac Electrophysiology 7, 95 103, 2002 C 2002 Kluwer Academic Publishers. Manufactured in The Netherlands. Analysis During Sinus Rhythm of Critical Sites in Reentry Circuits
More informationEarly Recurrence of Atrial Fibrillation After Ambulatory Shock Conversion
Journal of the American College of Cardiology Vol. 40, No. 1, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01912-5
More informationQRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators
Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.060
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review
More informationNeed to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia
Need to Know: Implantable Devices Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia Disclosure Statement I have no relationships to disclose. Objectives Discuss the most
More informationUsing an external radio-frequency energy transmitter to
Comparing the Efficacy and Safety of a Novel Monophasic Waveform Delivered by the Passive Implantable Atrial Defibrillator With Biphasic Waveforms in Cardioversion of Atrial Fibrillation Ganesh Manoharan,
More informationDefibrillation testing should be routinely performed at the time of implantable cardioverter-defibrillator implantation Contra
Defibrillation testing should be routinely performed at the time of implantable cardioverter-defibrillator implantation Contra Fernando Arribas Cardiology Service Hospital 12 de Octubre Madrid Spain D.O.I.
More informationNew generations pacemakers and ICDs: an update
Advances in Cardiac Arrhythmias and Great Innovations in Cardiology XXVII Giornate Cardiologiche Torinesi New generations pacemakers and ICDs: an update Prof. Fiorenzo Gaita, MD Division of Cardiology
More informationNEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS
NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS OBJECTIVES Discuss history of ICDs Review the indications for ICD and CRT therapy Describe basic lead and device technology Discuss different therapies
More informationMicrovolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction
Journal of the American College of Cardiology Vol. 47, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.026
More informationExperience with pectoral versus abdominal implantation of a small defibrillator
European Heart Journal (1998) 19, 185 198 Article No. hj9816 Experience with pectoral versus abdominal implantation of a small defibrillator A multicenter comparison in 778 patients E. Hoffmann, G. Steinbeck,
More informationThe New England Journal of Medicine
Brief Report CLINICAL CONSEQUENCES OF ELECTROCARDIOGRAPHIC ARTIFACT MIMICKING VENTRICULAR TACHYCARDIA BRADLEY P. KNIGHT, M.D., FRANK PELOSI, M.D., GREGORY F. MICHAUD, M.D., S. ADAM STRICKBERGER, M.D.,
More informationICD Treatment in Patients with Severe Ventricular Tachycardia
386 September 2001 ICD Treatment in Patients with Severe Ventricular Tachycardia O.T. GRECO, A. CARDINALLI NETO, M.J. SOARES, A.C. BRANDI, C.A. SANTOS, J.M. BRANDI, D.M. BRAILE Hospital de Base, Faculdade
More informationInteractive Simulator for Evaluating the Detection Algorithms of Implantable Defibrillators
22 March 2002 Interactive Simulator for Evaluating the Detection Algorithms of Implantable Defibrillators F. HINTRINGER, O. PACHINGER Division of Cardiology, Department for Internal Medicine, University
More informationSubcutaneous ICD Emerging Role of Sudden Cardiac Death Prevention
Subcutaneous ICD Emerging Role of Sudden Cardiac Death Prevention Dr Ngai-Yin Chan, MBBS, FRCP(Lond), FRCP(Edin), FRCP(Glasg), FACC, FHRS, Consultant Physician, Department of Medicine & Geriatrics, Princess
More informationShock Reduction Strategies Michael Geist E. Wolfson MC
Shock Reduction Strategies Michael Geist E. Wolfson MC Shock Therapy Thanks, I needed that! Why Do We Need To Reduce Shocks Long-term outcome after ICD and CRT implantation and influence of remote device
More informationCME Article Brugada pattern masking anterior myocardial infarction
Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University
More informationInitial Clinical Experience With Ambulatory Use of an Implantable Atrial Defibrillator for Conversion of Atrial Fibrillation
Initial Clinical Experience With Ambulatory Use of an Implantable Atrial Defibrillator for Conversion of Atrial Fibrillation Emile G. Daoud, MD; Carl Timmermans, MD; Chris Fellows, MD; Robert Hoyt, MD;
More informationAutomatic External Defibrillators
Last Review Date: April 21, 2017 Number: MG.MM.DM.10dC3v4 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationHelen S. Barold, MD, MPH, FACC, FHRS
Helen S. Barold, MD, MPH, FACC, FHRS Education: ScB 1987 Brown University, Providence RI ScB with Honors in Psychology Harold Schlosberg Memorial Premium in Psychology M.D. 1991 University of Rochester
More informationThe Immediate Reproducibility of T Wave Alternans During Bicycle Exercise
Reprinted with permission from JOURNAL OF PACING AND CLINICAL ELECTROPHYSIOLOGY, Volume 25, No. 8, August 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418. The Immediate Reproducibility
More informationAn Official Journal of the American Heart
Circulation Research An Official Journal of the American Heart SEPTEMBER VOL. XXIII Association 8 NO. Incidence of Arrhythmias in the Dog Following Transthoracic Ventricular Defibrillation with Unidirectional
More informationUse of Electrophysiologic Testing in Patients With Nonsustained Ventricular Tachycardia Prognostic and Therapeutic Implications
JACC Vol. 14, No. I July 1 8 1 5 5-61 155 ELECTROPHYSIOLOGIC STUDIES Use of Electrophysiologic Testing in Patients With Nonsustained Ventricular Tachycardia Prognostic and Therapeutic Implications RICHARD
More informationDual-Chamber Implantable Cardioverter-Defibrillator
February 1998 9 Dual-Chamber Implantable Cardioverter-Defibrillator A.SH. REVISHVILI A.N. Bakoulev Research Center for Cardiovascular Surgery, Russian Academy of Medical Sciences, Moscow, Russia Summary
More informationElectrophysiology and Cathether Ablation: Historical Evolution. Saverio Iacopino, MD, FACC, FESC
Electrophysiology and Cathether Ablation: Historical Evolution Saverio Iacopino, MD, FACC, FESC Historical Evolution ü 1967 ü 1968 ü 1969 ü 1973 ü 1979 Durrer D et al. first described initiation and termination
More informationWhat Every Physician Should Know:
What Every Physician Should Know: The Canadian Heart Rhythm Society estimates that, in Canada, sudden cardiac death (SCD) is responsible for about 40,000 deaths annually; more than AIDS, breast cancer
More information2010 Canadian Cardiovascular Society/ Canadian Heart Rhythm Society Training and Maintenance of Competency in Adult Clinical Cardiac
2010 Canadian Cardiovascular Society/ Canadian Heart Rhythm Society Training and Maintenance of Competency in Adult Clinical Cardiac Electrophysiology Martin S. Green, Chair, CHRS Education Committee Peter
More informationInappropriate ICD Discharge Related to Electrical Muscle Stimulation in Chiropractic Therapy: A Case Report
Cardiol Ther (2017) 6:139 143 DOI 10.1007/s40119-017-0086-6 CASE REPORT Inappropriate ICD Discharge Related to Electrical Muscle Stimulation in Chiropractic Therapy: A Case Report Abhishek Shenoy. Abhishek
More informationPotassium Efflux from Myocardial Cells Induced by Defibrillator Shock
Purdue University Purdue e-pubs Weldon School of Biomedical Engineering Faculty Publications Weldon School of Biomedical Engineering 1986 Potassium Efflux from Myocardial Cells Induced by Defibrillator
More informationThe Automated Defibrillator: A Biomedical Engineering Success Story. Dr. James A. Smith
The Automated Defibrillator: A Biomedical Engineering Success Story Dr. James A. Smith A Aorta VCS Superior Vena Cava RA Right Atrium RV Right Ventricle LV Left Ventricle The Heart Beating Heart: Video
More informationSubcutaneous Implantable Cardioverter Defibrillator (ICD) System
Subcutaneous Implantable Cardioverter Defibrillator (ICD) System Policy Number: Original Effective Date: MM.06.025 07/01/2015 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 3/24/2017
More informationClinical Results with the Dual-Chamber Cardioverter Defibrillator Phylax AV - Efficacy of the SMART I Discrimination Algorithm
April 2000 107 Clinical Results with the Dual-Chamber Cardioverter Defibrillator Phylax AV - Efficacy of the SMART I Discrimination Algorithm B. MERKELY Semmelweis University, Dept. of Cardiovascular Surgery,
More informationPrognostic Importance of Defibrillator Shocks in Patients with Heart Failure
original article Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure Jeanne E. Poole, M.D., George W. Johnson, B.S.E.E., Anne S. Hellkamp, M.S., Jill Anderson, R.N., David J. Callans,
More informationCATHETER ABLATION FOR TACHYCARDIAS
190 CATHETER ABLATION FOR TACHYCARDIAS MASOOD AKHTAR, M.D. T ACHY ARRHYTHMIAS constitute a major cause of mortality and morbidity. The most serious manifestation of cardiac arrhythmia is sudden cardiac
More informationTitle: Automatic External Defibrillators Division: Medical Management Department: Utilization Management
Retired Date: Page 1 of 7 1. POLICY DESCRIPTION: Automatic External Defibrillators 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management, Pharmacy,
More informationTASER and In-Custody Deaths
TASER and In-Custody Deaths Cardiac Effects of Conducted Electrical Weapons Patrick Tchou, MD Heart and Vascular Institute What is a stun gun? A device that delivers rapid electrical impulses that stimulates
More informationFigure 2. Normal ECG tracing. Table 1.
Figure 2. Normal ECG tracing that navigates through the left ventricle. Following these bundle branches the impulse finally passes to the terminal points called Purkinje fibers. These Purkinje fibers are
More information